EU set to introduce SPC manufacturing waiver, while uncertainty continues over unitary regime
The European Commission last week proposed a waiver allowing generic and biosimilar drug companies to manufacture products protected by Supplementary Protection Certificates (SPCs) for export. The proposal will meet with disapproval from pharma…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.